TESTIMONIALS

“It was an outstanding venue and format.  The event created an open dialogue between pharma and providers which helped to reveal strengths and weaknesses in the drug discovery and development process”
Bill Campbell VP, Discovery Technologies, Millenium Pharmaceuticals

“The format of the NGP Summit s a welcome departure from your typical meeting.  I found that it really helped to foster greater networking and communication between delegates and solution providers.  A very productive meeting.”
Matthew Pando, VP R&D, Exonhit

“The event was truly engaging and the format was terrific, informative and provocative.  While I have worked with both Michael Shi (Novartis) and Robert Pietrusko (Viropharma) who have attended the NGP Sumit before, I had not contacted them to discuss their experience.  They both were as enthusiastic the second time around.  As I said to a few, I recently attended DIA, but got more leads out of the 2 days at the NGP Summit than the 4 days at DIA.”
Angus Grant VP, Regulatory Affairs, Celgene

“The program was well organized and promoted great interactions.  It was very well run and the NGP staff should be highly congratulated for organizing this event!”
Charles Bisgaier, President, Pipex

“The NGP meeting was the most effective executive summit I have attended.  The knowledge and contacts I gained during the meetings will help Pfizer achieve its strategic goals.  I have made quite a few contacts who I will actually use to do business with.”
Giles Day Senior Director, Targets & Mechanisms Informatics,  Pfizer

“I have found the summit immensely enjoyable, I’ve made a lot of new contacts with some companies I wasn’t aware of and I’ve been made aware of new technologies that I will certainly discuss with my colleagues.”
David Nicholson, EVP, R&D, Organon

“It’s been a good summit and I’ve had opportunity to interact with lots of vendors and see new technologies that I think will be applicable to our business.”
Alejandro Arruffo VP, Global Pharmaceutical Development, Abbott

“I’ve been very, very impressed across the board. It was exceptionally well organized, from the organization prior to the event and the choice of location, to the quality of the delegates and attendees it has been first rate. Very high-level meetings and very focused at a strategic level, which you don’t typically find at many events like this. This is the Gold Standard and I have attended quite a few events in the industry.  I’m extremely happy that I came and I look forward to more events like this with NGP in the future.”
Nosa Omigui, Founder & CEO, Nervana

“This summit has been really helpful from our perspective. We’ve had some real quality discussions with people that are decision makers or able to put us in touch with the decision makers. It’s been a great fit for us to be here and be a part of this and get some useful input back. Excellent.” 
Auro Nair, Associate General Manager, Product Development, Marketing & Customer Service, Jackson Laboratories

“The conference was a great opportunity to meet a lot of people in a very short time rather than having to set up two hour meetings in a busy schedule. It’s a great opportunity to get contact with those people you wouldn’t necessarily let them in the door because I don’t know enough about them. It’s great for those small companies to get the chance to talk to those in bigger companies   This is the first time I’ve been to this conference and its format is very different to any pharmaceutical development conference I’ve ever been to and is really outstanding in terms of having much more time to interact with the other participants and to ask in depth questions and have a dialogue. I have found it very, very productive with the people I’ve met and the information I have been exposed to.” 
Doug Sporn, (Formerly) Divisional VP, Regulatory Intelligence & FDA Liason Office, Abbott

“This has exceeded my expectations in that I’m learning a lot from the workshops and discussions held by leaders in the industry and that’s been fantastic. The meeting room and having the chance to speak one-on-one with some vendors in a relaxed environment has been great and the whole show has been run very efficiently and very productively and I would sure like to come back again.”
Mel Reichman, Senior Investigator & Director Lankenau Institute for, Medical Research

“Terrific concept on the conference, allowing for really deep discussions with vendors and hearing very timely thematic topics in the workshop sessions.
Richard Soll VP, R&D and CSO, TargeGen

“I’ve really enjoyed the format of the meetings, it’s been a good mix of networking with delegates and meeting vendors I may not have otherwise run into. I’ve had a lot of good conversations both with vendors, their standpoint and what they have to offer and I’ve been making good connections with delegates. It’s been a very productive summit for me.”
Matthew Pando, VP, R&D, Exonhit

“For me the NGP conference has been very interesting from the point of view that folks in safety are typically down the line in development and it is clearly an evolving notion that we need to be involved and by coming to these meetings it has been increasingly clear to me that technology that is now primarily focusing on the effectiveness area that holds tremendous promise for helping us identify safety issues more reliably and quickly. In a nutshell it has been a very productive summit. One of the most interesting things about it is that everyone I have met I could see a potential application in.”
John Ferguson, VP, Pharmacovigilence,  Novartis

“I’m pleased to have been at the summit this year, it’s been a really exciting opportunity and I’ve met a lot of interesting people and learned a lot and actually found a lot of solutions and tools that will help me advance our science.”
Christine Sapan, EVP & Chief Development Officer, Neurologix

“Absolutely the most valuable event I’ve been to in the past couple of years. The ability to have meaningful conversations and to know senior executives in the industry and to build relationships that will last a long time has been phenomenal.”
Pete Krainik, Executive Vice President, QD Technology

“I truly enjoyed this process of meeting potential solution providers one on one.  NGP did the most fantastic job taking care of their delegates!”
Rakesh Dixit, Senior Director, R&D & Head, Toxicology Translational Sciences, MedImmune

“Overall, congratulations on a great job!  We will certainly plan to attend the next event if the focus meets our strategic objectives.”
Martin Stuart, VP, Worldwide Sales, Aperio

“I had a very enriching experience.  I was exposed to new technologies that I did not know before and met very open and nice people.  The organization of the conference was very well done.”
Ali Fattom, VP, Research, Nabi Biopharmaceuticals

“I have really enjoyed the meetings and it was a great opportunity to meet all the people in the industry – good organization and design meant I could meet many people in two days.”
Eric Zanelli, VP, Research, Peptimmune

“This has been a good opportunity to have in-depth discussions with people that you wouldn’t think had solutions for you and it turns out that they do.”
Jim Winkler, VP, Discovery & Translational Biology, Array BioPharma